Impact of the loss of Laboratory Developed Mass Spectrometry testing at a major academic medical center

BACKGROUND: Our laboratory historically performed immunosuppressant and definitive opioid testing in-house as laboratory developed (LDT) mass spectrometry-based tests. However, staffing constraints and supply chain challenges associated with the COVID-19 pandemic forced us to refer this testing to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Geno, K. Aaron, Cervinski, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938756/
https://www.ncbi.nlm.nih.gov/pubmed/36846026
http://dx.doi.org/10.1016/j.jmsacl.2023.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938756/
https://www.ncbi.nlm.nih.gov/pubmed/36846026
http://dx.doi.org/10.1016/j.jmsacl.2023.02.005

Ejemplares similares